Factors associated with pretreatment and treatment dropouts among clients admitted to medical withdrawal management

Journal of Addictive Diseases

Volumn 26, Issue 3, 2007, Pages 77-85

  Li, Xin ^a   Sun, Huiying ^b   Puri, Ajay ^c   Marsh, David C ^a   Anis, Aslam H ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

^c Providence Health Care   (Canada)

Author keywords

Detoxification; Pretreatment dropout; Substance use disorders; Treatment dropout; Withdrawal management

Indexed keywords

ALCOHOL; METHADONE; OPIATE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL DECISION MAKING; DEMOGRAPHY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEALTH CARE UTILIZATION; HEPATITIS C; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METHADONE TREATMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPIATE ADDICTION; PATIENT ATTITUDE; RISK FACTOR; SEX RATIO; TREATMENT WITHDRAWAL;

ADULT; CANADA; DEMOGRAPHY; ETHANOL; FEMALE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; PATIENT ADMISSION; PATIENT DROPOUTS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 34548378634     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v26n03_08     Document Type: Article

References (33)

1. Myrick H, Anton R, Kasser CL. Management of intoxication and withdrawal: general principles. In Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB (eds.): Principles of addiction medicine. Third edition. 2003: 611-20.
2. Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, three-, six-month outcomes after inpatient opioid detoxification. Am. J. Drug Alcohol Abuse. 2001; 27(1): 19-44.
3. Endicott P, Watson B. Interventions to improve the AMA-discharge rate for opiate-addicted patients. J Psychosocial Nursing Mental Health Services. 1994; 32(8): 36-40.
4. Gossop M, Johns A, Green L. Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. Br Med J. (Clin. Res. Ed.) 1986; 293(6539): 103-4.
5. Luippold R, Zorn M, Lewis BF. Outcomes of a 21-days detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am. J. Drug Alcohol Abuse. 1995; 21: 1-16.
6. Stark MJ. Dropping out of substance abuse treatment: A clinically oriented review. Clin. Psychol. Rev. 1992; 12: 93-116.
7. Armenian, SH, Chutuape, MA, Stitzer ML. Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend. 1999; 56: 1-8.
8. Backmund M, Meyer K, Eichenlaub, D, Schutz, CG. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug Alcohol Depend. 2001; 64: 173-180.
9. Broers B, Giner, F, Dumont P, Mino A. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months. Drug Alcohol Depend. 2000; 58: 85-92.
10. Martinez-Raga J, Marshall EJ, Keaney F, Ball D, Strang J. Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 first-episode admissions. Alcohol and Alcoholism. 2002; 37(3): 277-81.
11. McCusker J, Bigelow C, Luippold R, Zorn M, Lewis BF. Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am. J. Drug Alcohol Abuse. 1995; 21(1): 2-18.
12. de los Cobos JP, Trujols J, Ribalta E, Casas M. Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. Am. J. Drug Alcohol Abuse. 1997; 23: 267-79.
13. Franken IHA, Hendriks VM. Predicting outcome of inpatient detoxification of substance abusers. Psychiatr Serv. 1999; 50(6): 813-7.
14. Callaghan RC, Cunninghan JA. Gender differences in detoxification: predictors of completion and re-admission. J Subst Abuse Treat. 2002; 23: 399-407.
15. Donovan, DM, Rosengren, DB, Downey L, Cox GB, Sloan KL. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction. 2001;96(8): 1149-60.
16. Hser YI, Maglione M, Polinsky ML, Anglin D. Predicting drug treatment entry among treatment-seeking individuals. J Subst. Abuse Treat. 1998; 15: 213-20.
17. Gottheil E, Sterling RC, Weinstein SP. Pretreatment dropouts: characteristics and outcomes. J Addict Dis. 1997; 16(2): 1-14.
18. Stark MJ, Campbell BK, Brinkerhoff CV. "Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am J Drug Alcohol Abuse. 1990; 16: 67-76.
19. Festinger DS, Lamb RJ, Kountz MR, Kirby KC, Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addictive Behaviors. 1995; 20(1): 111-5.
20. Festinger DS, Lamb RJ, Marlowe DB, Kirby KC. From telephone to office-intake attendance as a function of appointment delay. Additive Behaviors. 2002; 27(1): 131-7.
21. Stasiewicz PR, Stalker R. Brife report a comparison of three "interventions" on pretreatment dropout rates in an outpatient substance abuse clinic. Addictive Behaviors. 1999; 24(4): 579-82.
22. Vendetti, J, McRee B, Miller M, Christiansen K, Herrell J, The Marijuana Treatment Project Research Group. Correlates of pre-treatment drop-out among persons with marijuana dependence. Addiction. 2002; 97 (suppl 1): 125-34.
23. Weisner C, Mertens, J, Tam T, Moore C. Factors affecting the initiation of substance abuse treatment in managed care. Addiction. 2001; 96: 705-16.
24. MacMillanm H, MacMillan A, Offord D, Dingle J. Aboriginal health. CMAJ. 1996; 155: 1569-78.
25. British Columbia Ministry of Health. Analysis of status of Indians in British Columbia: 1991-1997. Victoria, BC: British Columbia Ministry of Health. 1998.
26. Callaghan RC. Risk factors associated with dropout and readmission among First Nations individuals admitted to an inpatient alcohol and drug detoxification program. CMAJ. 2003; 169(1): 23-7.
27. LaWall JS, Jones R. Discharges from a ward against medical advice: search for a profile. Hosp. Comm. Psychiatry. 1980; 31: 415-6.
28. Schechter MT, O'Shaughnessy MV. Distribution of injection drug users in the Lower Mainland. BC Medical Journal. 2000; 42 (2):80-8.
29. Tyndall MW, Kerr T, Zhang R, Montaner JS, & Wood E. HIV prevalence among injection drug users attending the supervised injection site in Vancouver. Can J Infect Dis Med Microbiol. 2005; Vol 16, Suppl A: 15.
30. Anis AH, Sun H, Guh DP, Palepu A, Schechter MT, O'Shaughnessy MV. Leaving hospital against medical advice among HIV-positive patients. CMAJ. 2002; 167(6): 633-7.
31. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51: 253-63.
32. Zanis D, McLellan A, Randall M. Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend. 1994; 35: 127-32.
33. Durran GM, Kirchner JE, Worley M, Rookey C, Booth B. Depressive symptomatology and early attrition from intensive outpatient substance use treatment. J Behav Health Serv Res. 2002; 29(2): 138-43.